| 0 |
MESENTERIC PANNICULITIS |
1 |
0.0033 |
| 1 |
BLOOD TESTOSTERONE INCREASED |
2 |
0.0009 |
| 2 |
JAUNDICE CHOLESTATIC |
3 |
0.0008 |
| 3 |
DEAFNESS BILATERAL |
1 |
0.0006 |
| 4 |
UPPER RESPIRATORY TRACT CONGESTION |
1 |
0.0003 |
| 5 |
THORACIC VERTEBRAL FRACTURE |
1 |
0.0003 |
| 6 |
METASTASES TO SPINE |
1 |
0.0003 |
| 7 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 8 |
AGRANULOCYTOSIS |
5 |
0.0003 |
| 9 |
SUBSTANCE ABUSE |
2 |
0.0002 |
| 10 |
ANGIOPATHY |
1 |
0.0002 |
| 11 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 12 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 13 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 14 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
2 |
0.0001 |
| 15 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 16 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 17 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 18 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 19 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 20 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 21 |
METASTASES TO BONE |
1 |
0.0001 |
| 22 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 23 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 24 |
URINARY RETENTION |
2 |
0.0001 |
| 25 |
HEMIPARESIS |
1 |
0.0001 |
| 26 |
HAEMATURIA |
2 |
0.0001 |
| 27 |
METASTASES TO LIVER |
1 |
0.0001 |
| 28 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 29 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 30 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 31 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 32 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 33 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 34 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 35 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 36 |
TINNITUS |
1 |
0.0000 |
| 37 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 38 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 39 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 40 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 41 |
CONVULSION |
1 |
0.0000 |
| 42 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 43 |
VERTIGO |
1 |
0.0000 |
| 44 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 45 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 46 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 47 |
BACK PAIN |
3 |
0.0000 |
| 48 |
DRUG INTERACTION |
2 |
0.0000 |
| 49 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 50 |
BREAST CANCER |
1 |
0.0000 |
| 51 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 52 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 53 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 54 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 55 |
ANXIETY |
2 |
0.0000 |
| 56 |
MALAISE |
3 |
0.0000 |
| 57 |
FATIGUE |
5 |
0.0000 |
| 58 |
PARAESTHESIA |
1 |
0.0000 |
| 59 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 60 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 61 |
FALL |
2 |
0.0000 |
| 62 |
MYALGIA |
1 |
0.0000 |
| 63 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 64 |
ASTHENIA |
2 |
0.0000 |
| 65 |
DRUG INEFFECTIVE |
7 |
0.0000 |
| 66 |
DYSPNOEA |
3 |
0.0000 |
| 67 |
ALOPECIA |
1 |
0.0000 |
| 68 |
FEELING ABNORMAL |
1 |
0.0000 |
| 69 |
INSOMNIA |
1 |
0.0000 |
| 70 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 71 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 72 |
PYREXIA |
1 |
0.0000 |
| 73 |
NAUSEA |
2 |
0.0000 |
| 74 |
HEADACHE |
1 |
0.0000 |